Alderley Park


Back to All Events

‘De-risking the Valley of Death – How R&D companies can access the knowledge network to maximise success’

  • Edmond Safra Lecture Said Business School Park End St, Oxford OX1 1HP (map)

Join OBN for their first BioTuesday event of 2018 featuring Alderley Park's Managing Director, Dr Chris Doherty and BioHub Director, Ned Wakeman.

The Valley of Death phase in the development of an R&D company is identified as the phase from one to six years, where they are moving from lead generation through to phase 1 development. There are many hurdles and challenges to overcome during this time and many companies falter, hence the reference to the ‘Valley of Death’.

Via a series of insightful keynotes and case studies this BioTuesday event will look at how R&D companies can bridge the valley by accessing and fully utilising the existing knowledge network.

In addition to our keynote speakers, we will hear from several companies based at the BioHub in Alderley Park who have successfully utilized the knowledge and expertise network of ex-Astra Zeneca scientists after the company move from Alderley Park to Cambridge.


17:30 Registration

18:00 Welcome:

John Harris | CEO, OBN
Ned Wakeman | Director, BioHub at Alderley Park

18:10 Keynotes:

Dr Chris Doherty | ‎Managing Director, Alderley Park, ‎Manchester Science Partnerships

Dr Nick Scott-Ram | Director of Commercial Development, Oxford Academic Health Science Network

Peter Dines | Investment Director, Head of Life Sciences, Fund Manager, Mercia EIS Funds

18:40 Presentations from companies who have thrived after accessing talent from the knowledge network:

ApconiX – an integrated toxicology and ion channel company at the forefront of innovative thinking in nonclinical toxicology and safety science

Aptus Clinical – who specialise in the provision of expert clinical research professionals

Seda Pharmaceutical Development Services – provide Pharmaceutical Development Services, Clinical Pharmacology Services and Consultancy for the Pharma Industry

Blueberry therapeutics - bring high value, innovative medicines to the market and have exclusive worldwide access to a nanodelivery platform, which significantly enhances delivery of drugs into cells and tissues

19:10 Panel discussion

19:30 Q&A

20:00 - 21:00 Networking over drinks and canapés

This event is kindly supported by BioHub at Alderley Park.


OBN Member - first ticket complimentary, additional ticket £25+VAT

Non Members - £50+VAT